<?xml version="1.0" encoding="UTF-8"?>
<ref id="B1">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Abdelsamie</surname>
    <given-names>A. S.</given-names>
   </name>
   <name>
    <surname>Salah</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Siebenbürger</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Merabet</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Scheuer</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Frotscher</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2019</year>). 
  <article-title>Design, synthesis, and biological characterization of orally active 17β-hydroxysteroid dehydrogenase type 2 inhibitors targeting the prevention of osteoporosis</article-title>. 
  <source>J. Med. Chem.</source>
  <volume>62</volume> (
  <issue>15</issue>), 
  <fpage>7289</fpage>–
  <lpage>7301</lpage>. 
  <pub-id pub-id-type="doi">10.1021/acs.jmedchem.9b00932</pub-id>
  <pub-id pub-id-type="pmid">31343176</pub-id>
 </mixed-citation>
</ref>
